Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Pfizer
04:15 PM EDT, 05/07/2021 (MT Newswires) -- Jennifer B Damico, SVP & Controller, on May 05, 2021, sold 2,500 shares in Pfizer (PFE) for $102,050. Damico, subsequent to the transactions described in the SEC Form 4 filing, has 13,748 shares of the company, with a market value, based on the prior-day closing price, of $538,784.
In the 90 days previous to the date of this filing, there have been 45 insider transactions reported to the SEC for Pfizer. These transactions came from the activities of 12 different insiders that resulted in a net acquisition of 210,610 company shares. Relative to the preceding 90-day window of time, there were 6 transactions from 5 insiders that resulted in the net disposition of 180,556 shares.
This level of transactions is below that of the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Within the peer group activity averaged 64.3 transactions per company, and disposition of 7,245 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/78003/000122520821007736/xslF345X03/doc4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.